Showing results (101-110 of 410) with videos related to

Sort By:
Pageof 41
Annals of Hematology|September 1, 2001
Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in childrenG Mann, D Reinhardt, J Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease GroupG Schellong, M Riepenhausen, U Creutzig, et al.
Klinische Padiatrie|September 3, 1999
[Prognosis, treatment completion, and complications in nonresponders in the study AML-BFM87]V Kallage, J E Müller, M Zimmermann, et al.
Klinische Padiatrie|July 1, 1992
[Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study]K Stahnke, J Ritter, G Schellong, et al.
European Journal of Medical Research|July 31, 1998
Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot studyA Böhme, P M Shah, W Stille, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
High release of tumor necrosis factor alpha, interferon gamma and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cellsJ Koberda, L Bergmann, P S Mitrou, et al.
Leukemia|August 1, 1994
Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cellsS J Baker, M Pawlita, A Leutz, et al.
Leukemia Research|January 1, 1985
Mixed megakaryocytic-granulocytic differentiation during diffusion chamber culture of peripheral blast cells from the blast crisis of chronic myelocytic leukemiaA Ganser, F Carbonell, P M Lansdorp, et al.
The Journal of Infection|November 20, 1998
Prospective randomized study to compare imipenem 1.5 grams per day vs. 3.0 grams per day in infections of granulocytopenic patientsA Böhme, P M Shah, W Stille, et al.
Onkologie|February 1, 1989
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot studyA Ganser, O G Ottmann, G Schulz, et al.
Pageof 41